Form 4: Hims & Hers CLO Soleil Boughton Sells Shares
Statement of Changes in Beneficial Ownership
Chief Legal Officer Soleil Boughton sold 9,463 shares of Hims & Hers Health, Inc. stock via a 10b5-1 trading plan.
Summary
- Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 9,463 shares of Class A Common Stock.
- The transaction occurred on April 20, 2026, at a price of $30.00 per share.
- Following the transaction, the reporting person retains ownership of 299,368 shares.
- The sale was executed under a pre-established Rule 10b5-1 trading plan adopted on November 18, 2025.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed under a pre-planned 10b5-1 arrangement, which is standard practice and does not necessarily reflect a change in management's outlook on the company.
Positives
- The sale was conducted through a pre-planned Rule 10b5-1 trading plan, which is a standard mechanism for executives to sell shares without triggering insider trading concerns.
Negatives
- The transaction represents a reduction in the direct equity stake held by a key member of the executive leadership team.
Risks
- Executive stock sales can sometimes be perceived negatively by retail investors as a signal of management sentiment regarding future stock performance.
Future Outlook
No forward-looking guidance or operational outlook was provided in this filing.
Industry Context
StockSavvy.ai notes that executive selling via 10b5-1 plans is a routine corporate governance practice in the telehealth and consumer health sector, intended to provide liquidity for insiders while maintaining regulatory compliance.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for executives at publicly traded companies like Hims & Hers to manage personal equity holdings.
- The scale of the sale relative to the total holdings (approximately 3%) is consistent with typical periodic diversification strategies for corporate officers.
Stakeholder Impact
- Minimal impact expected on shareholders as the sale was pre-planned and represents a small portion of the executive's total holdings.
Next Steps
- Continued monitoring of future Form 4 filings for additional insider activity.
Key Dates
| Date | Description |
|---|---|
| 2025-11-18 | Date the Rule 10b5-1 trading plan was adopted. |
| 2026-04-20 | Date of the reported stock sale transaction. |
| 2026-04-22 | Date the Form 4 was signed and filed. |
Keywords
Hims & Hers, HIMS, Insider Trading, Form 4, Executive Compensation, Soleil Boughton
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.